Governance

The IPM Alliance is guided by an international network of leaders, scientists, clinicians, public health experts and policy specialists. Its governance and expert structure connects strategic oversight with scientific and implementation expertise across personalised medicine, oncology, diagnostics, digital health, public health and health system readiness.

See more

Leadership

Board of Directors

The Board of Directors provides strategic oversight and guidance for IPM Alliance, helping to shape its international direction, public-interest mission and long-term institutional development.

Board Chair

Prof. Marcel Tanner

Europe, Switzerland

Swiss TPH; University of Basel; Swiss Academy of Sciences (SCNAT)

Global Health
Health Systems
Implementation Science
Public Health
View profile
Board Member

Prof. Elil Renganathan

Asia, Malaysia

Monash University Malaysia

Global Health
Health Policy
Health Systems
Public Health
View profile
Board Member

H.E. Sheikh Dr. Khalid Bin Jabor Al Thani

Middle East, Qatar

Qatar Cancer Society

Cancer Advocacy
Cancer Policy
Patient Support
Public Health
View profile
Board Member

Ms. Malebona Precious Matsoso

Africa, South Africa

Wits Health Consortium; University of the Witwatersrand

Access to Medicines
Global Health
Health Policy & Regulation
Regulatory Science
View profile
Board Member

Dr. Manmeet Singh Ahluwalia

North America, United States

Miami Cancer Institute, Baptist Health South Florida

Brain Tumors
Clinical Trials
Neuro-Oncology
Oncology
Precision Oncology
View profile
Board Member

Dr. Maria P. Neira

Europe, Spain

World Health Organization

Climate and Health
Environmental Health
Global Health
Public Health
View profile
Board Member

Prof. Ruggero De Maria

Europe, Italy

Università Cattolica del Sacro Cuore; Alleanza Contro il Cancro

Cancer Research
Oncology
Precision Oncology
Translational Medicine
View profile
Board Member, Leading Expert

Prof. Vivek Subbiah

North America, United States

Stanford University School of Medicine; Stanford Cancer Institute

Clinical Trials
Drug Development
Oncology
Precision Oncology
Rare Cancers
View profile
Board Member

Prof. Dr. Wenbin Li

Asia, China

Beijing Tiantan Hospital, Capital Medical University; National Health Care Big Data Research Institute, Capital Medical University

Brain Tumors
Clinical Trials
Neuro-Oncology
Oncology
Precision Oncology
View profile